Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


Lilly negotiating with telecommunications companies; sells Hybritech monoclonals business.

Executive Summary

LILLY PLANNING INVESTMENT IN TELEPHONALS AS IT DIVESTS 39424MONOCLONALS: behind the headlines of its recent Hybritech divestiture, the company is actively in negotiations with major telecommunication and computer firms to support its objective of building a health information network. Although the deals are not directly related, the new focus on telecommunication skills shows the change in synergies between the mid-80's and mid-90's. Lilly Chief Information Officer Tom Trainer discussed the telecommunications negotiations at a Sept. 26 meeting in London at which he described the effort as "aggressive discussions."

You may also be interested in...

Lilly Gets Protein Optimization System In Applied Molecular Evolution Deal

Lilly's acquisition of Applied Molecular Evolution will give the company access to technology for optimizing proteins and genes for specific therapeutic targets

Part D Discount Liability Coming Into Focus: CMS Releases Drug Cost Data

Newly released Medicare Part D data sheds light on the sales hit that branded pharmaceutical manufacturers will face when the coverage gap discount program gets under way in 2011




Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts